Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
Clinical trial NCT05689034 · RECRUITING
Trial details
- NCT number
- NCT05689034
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2025-06-30
- Enrollment
- 1096
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.